NASDAQ · Biotechnology

NBTX (NBTX) Stock

$41.67 +6.06% NASDAQ: NBTX Healthcare

Valuation

MetricValue
Price$41.67
Market Cap$2.11B
P/E Ratio-69.06
P/B Ratio-19.77
P/S Ratio60.36
EPS (TTM)$0.13
52-Week High$57.14
52-Week Low$8.03
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE31.23%
ROA-35.36%
ROCE-105.51%
Gross Margin-33.33%
Operating Margin-36.67%
Net Margin-80.83%
Debt/Equity-1.13
Current Ratio1.09

Annual Financials (USD)

Metric20212022202320242025
Revenue$3.0M$5.0M$36.0M$-7.0M$30.0M
Operating Profit$-53.0M$-47.0M$-27.0M$-68.0M$-11.0M
Net Profit$-47.0M$-57.0M$-40.0M$-68.0M$-24.0M
EPS$-1.35$-1.64$-1.08$-1.44$-0.50
Op Margin-1986.4%-977.9%-74.0%951.2%-36.5%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$102.0M$60.0M$94.0M$67.0M$68.0M
Total Liabilities$75.0M$87.0M$96.0M$133.0M$152.0M
Cash$84.0M$41.0M$75.0M$50.0M$53.0M
Borrowings$46.0M$53.0M$51.0M$51.0M$95.0M

Latest News

Nanobiotix (NBTX) Provides Update on Operational Progress Insider Monkey · Jun 22, 2026 Voting Rights and Shares Capital of the Company GlobeNewswire · Jun 5, 2026 Nanobiotix Provides First Quarter 2026 Operational and Financial Update GlobeNewswire · Jun 2, 2026 Nanobiotix Joins Euronext Tech Leaders Index MT Newswires · Jun 2, 2026 Nanobiotix Joins the Euronext Tech Leaders Index GlobeNewswire · Jun 2, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-30.0M$-37.0M$-12.0M$-20.0M$-33.0M
Investing Cash Flow$0$0$-1.0M$-2.0M$-1.0M
Financing Cash Flow$-1.0M$-1.0M$50.0M$-1.0M$-2.0M
Net Cash Flow$-35.0M$-43.0M$34.0M$-26.0M$3.0M
Free Cash Flow$-30.0M$-37.0M$-13.0M$-20.0M$-34.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-0.76
EV / EBITDA-151.80
FCF Yield-1.90%
Quick Ratio1.09
Interest Coverage-1.04
Return 1Y693.32%
Return 3Y339.39%
Return 5Y192.19%

Ownership

Insiders Held0.00%
Institutions Held11.76%
Institutions Float Held11.76%
Institutional HolderSharesReport Date
Johnson & Johnson5,623,8162026-03-31
Morgan Stanley36,2742026-03-31
Optiver Holding B.v.13,5012026-03-31
Marshall Wace LLP9,2392026-03-31
UBS Group AG5,5572026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ABUS $5.10 +0.20% 6.45 $1.01B 0.00%
EYPT $4.79 +4.59% -1.20 $401.60M 0.00%
GHRS $28.07 +2.60% -10.34 $1.92B 0.00%
KURA $13.11 +1.71% -3.89 $1.16B 0.00%
LENZ $5.80 +10.90% -1.39 $181.86M 0.00%

About NBTX

NBTX stock trades at $41.67 with a market capitalization of $2.11B. The stock is valued at a price-to-earnings (P/E) ratio of -69.06, price-to-book of -19.77, price-to-sales of 60.36. Over the past 52 weeks the stock has ranged between $8.03 and $57.14, and currently trades 27.1% below its 52-week high.

On profitability, NBTX generates a return on equity (ROE) of 31.23% — well above the market average, a sign of a high-quality business, return on capital employed of -105.51%, an operating margin of -36.67%, a net profit margin of -80.83%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1160.06 +0.01% JNJ Drug Manufacturers - General $275.21 +1.48% ABBV Drug Manufacturers - General $261.70 +0.66% MRK Drug Manufacturers - General $151.64 +1.19% UNH Medical - Healthcare Plans $399.66 +0.85% NVS Drug Manufacturers - General $162.46 +0.75% AZN Drug Manufacturers - General $161.63 -0.52% AMGN Drug Manufacturers - General $442.84 +1.08% TMO Medical - Diagnostics & Research $608.54 +1.34% NVO Biotechnology $46.77 +3.66% ABT Medical - Devices $110.49 +1.43% GILD Drug Manufacturers - General $149.61 -0.21%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides